Northwind Pharmaceuticals LLC recalls Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203
Recalled May 3, 2023 · FDA recall D-0550-2023 · Northwind Pharmaceuticals
Hazard
CGMP Deviations · FDA Class II
Units
33 bottles
Sold at
Nationwide with the United States
Description
CGMP Deviations
Product
Doxazosin Tablets, USP, 4mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-109-52
Manufacturer(s)
Northwind Pharmaceuticals LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →